The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flores, I.
Right arrow Articles by Mérida, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flores, I.
Right arrow Articles by Mérida, I.
The Journal of Immunology, 1998, 160: 3528-3533.
Copyright © 1998 by The American Association of Immunologists

Dual Role of Ceramide in the Control of Apoptosis Following IL-2 Withdrawal1

Ignacio Flores*, Carlos Martinez-A*, Yusuf A. Hannun{dagger} and Isabel Mérida2,*

* Department of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid, Spain; and {dagger} Departments of Medicine and Cell Biology, Duke University Medical Center, Durham NC 27710

Ceramide is largely known as a lipid second messenger with pleiotropic effects. Increases in ceramide levels have been related to the onset of apoptosis, terminal differentiation, or growth suppression. In this study, addition of exogenous C2-ceramide to CTLL-2 cells is found to block IL-2-induced cell cycle entry, as well as the apoptosis triggered by IL-2 deprivation. The protective effect of C2-ceramide is achieved only in the early stages following cytokine deprivation and is related to the inhibition of bcl-xL degradation and the induction of a G0 arrest of cells. The same treatment over a longer time when, as we demonstrate, ceramide is produced physiologically, enhances cell death by apoptosis. The dual effect of ceramide both in protecting from or inducing apoptosis is discussed further.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
L. R. Devireddy and M. R. Green
Transcriptional Program of Apoptosis Induction following Interleukin 2 Deprivation: Identification of RC3, a Calcium/Calmodulin Binding Protein, as a Novel Proapoptotic Factor
Mol. Cell. Biol., July 1, 2003; 23(13): 4532 - 4541.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. A. Sanjuan, D. R. Jones, M. Izquierdo, and I. Merida
Role of Diacylglycerol Kinase {alpha} in the Attenuation of Receptor Signaling
J. Cell Biol., April 2, 2001; 153(1): 207 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Flores, D. R. Jones, A. Cipres, E. Diaz-Flores, M. A. Sanjuan, and I. Merida
Diacylglycerol Kinase Inhibition Prevents IL-2-Induced G1 to S Transition Through a Phosphatidylinositol-3 Kinase-Independent Mechanism
J. Immunol., July 15, 1999; 163(2): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Aragones, D. R. Jones, S. Martin, M. A. S. Juan, A. Alfranca, F. Vidal, A. Vara, I. Merida, and M. O. Landazuri
Evidence for the Involvement of Diacylglycerol Kinase in the Activation of Hypoxia-inducible Transcription Factor 1 by Low Oxygen Tension
J. Biol. Chem., March 23, 2001; 276(13): 10548 - 10555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.